In Depth

Big pharma faces headwinds in China as vaccine sales decline

How can pharma manage rising trial costs?

Can AI replace medical writers? Experts say not immediately

Saving shelved ultra- rare therapies through unorthodox funding

Do in vivo CAR-T cell therapies have the potential to overtake ex vivo CAR-Ts?

Weight loss implants to increase compliance and cut admin burden for patients